Wixela vs Symbicort
What to choose Wixela or Symbicort
Wixela is inhaler of type Control while Symbicort is of Control type. Wixela and Symbicort are both brand inhalers. Wixela is manufactured by pharmaceutical company Viatris, while Symbicort is manufactured by AstraZeneca. The main substances of Wixela are Fluticasone and Salmeterol. The available dosage for Wixela is 250/50. The main substances of Symbicort are Budesonide and Formoterol. The available dosages for Symbicort are 100/6, 160/4.5, 200/6, 400/6.
The current cost for Wixela is approximately $240 while average price for Symbicort is roughly $359, said Beckett Flores, a Research Assistant at the California State University, Los Angeles and an Advanced Medical Support Assistant at a clinic that uses Wixela and Symbicort.
Wixela and Symbicort Comparison
| Wixela | Symbicort | |
|---|---|---|
| Type: | Control | Control |
| Manufacturer: | Viatris | AstraZeneca |
| Substance: | Fluticasone + Salmeterol | Budesonide + Formoterol |
| Dosage: | 250/50 | 100/6, 160/4.5, 200/6, 400/6 |
| Avg Price: | $240 | $359 |